Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Autor: Jan van den Brande, Tessa Uiterwaal, Christianne J. Buskens, Juda Vecht, Robert E G J M Pierik, Job H.C. Peters, Nofel Mahmmod, John Maring, E. Joline de Groof, Toer W. Stevens, H. B. A. C. Stockmann, Pieter C. F. Stokkers, Karlien F. Bruin, Eric J. Hazebroek, Ailsa Hart, Arnold van de Laar, Hubert A Prins, Richard van Hillegersberg, Rachel L. West, Paul Kingma, Menno A. Brink, Pritesh Morar, Ruud Schouten, Marno C.M. Rijk, A Jeroen de Groof, Sijbrand Hofker, Annekatrien Depla, Bregje Mol, Janneke van der Woude, T. J. Gardenbroek, Janindra Warusavitarne, Bas Oldenburg, Edwin S. van der Zaag, Anna A. W. van Geloven, Rogier M P H Crolla, Emma J. Eshuis, Hans Brouwer, Meindert N. Sosef, Maria L Haasnoot, Geert R. D'Haens, Nynke Talstra, Marcel Spanier, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Donald L. van der Peet, Nanne K. H. de Boer, Willem A. Bemelman, Cyriel Y. Ponsioen, Rosalie C Mallant, Theo J.M. van Ditzhuijsen, Gerard Dijkstra, Alexander P.J. Houdijk, Willem A. Marsman, Djuna Cahen, Casper G. Noomen, Huib A. Cense, Esther C. J. Consten, Michael F. Gerhards, Ad A. van Bodegraven, Rob J. Lieverse, Andreas Marinelli, Sjoerd van der Werff, Clemens Bolwerk, Ernst Jan Spillenaar Bilgen, Quirijn A. J. Eijsbouts, Guido Mannaerts, Bart A. van Wagensveld

Publikováno v: The lancet. Gastroenterology & hepatology, 5(10), 900-907. HANLEY & BELFUS-ELSEVIER INC
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited

BACKGROUND: The LIR!C trial showed that laparoscopic ileocaecal resection is a cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab, an anti-tumour necrosis factor (TNF) drug. We aimed to compare long-term o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5752a7757a14a7ceff01b5b9c7a95a
https://doi.org/10.1016/s2468-1253(20)30117-5

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Autor: Job H.C. Peters, Sijbrand Hofker, Marno C.M. Rijk, Theo J.M. van Ditzhuijsen, Donald L. van der Peet, Annekatrien Depla, John Maring, Hans Brouwer, Geert R. D'Haens, Anna A. W. van Geloven, Patrick M.M. Bossuyt, Huib A. Cense, Paul Kingma, Djuna Cahen, Meindert N. Sosef, Esther C. J. Consten, Arnold van de Laar, H. B. A. C. Stockmann, Emma J. Eshuis, Richard van Hillegersberg, Ernst Jan Spillenaar Bilgen, Karlien F. Bruin, Bregje Mol, Alexander P.J. Houdijk, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Robert E G J M Pierik, Gerard Dijkstra, Hubert A Prins, Rogier M P H Crolla, Rosalie C Mallant, Nanne K. H. de Boer, Jan van den Brande, Michael F. Gerhards, Ad A. van Bodegraven, Menno A. Brink, Bas Oldenburg, Pritesh Morar, Janneke van der Woude, Janindra Warusavitarne, Tjibbe J. Gardenbroek, E. Joline de Groof, Pieter C. F. Stokkers, Rob J. Lieverse, Eric J. Hazebroek, Marcel Spanier, Casper G. Noomen, Willem A. Bemelman, Cyriel Y. Ponsioen, Andreas Marinelli, Juda Vecht, Ailsa Hart, Nynke Talstra, Willem A. Marsman, Tessa Uiterwaal, Christianne J. Buskens, Nofel Mahmmod, Rachel L. West, A Jeroen de Groof, Sjoerd van der Werff, Clemens Bolwerk, Quirijn A. J. Eijsbouts, Edwin S. van der Zaag, Ruud Schouten, Bart A. van Wagensveld, Guido Mannaerts

Publikováno v: Ponsioen, C Y, de Groof, E J, Eshuis, E J, Gardenbroek, T J, Bossuyt, P M M, Hart, A, Warusavitarne, J, Buskens, C J, van Bodegraven, A A, Brink, M A, Consten, E C J, van Wagensveld, B A, Rijk, M C M, Crolla, R M P H, Noomen, C G, Houdijk, A P J, Mallant, R C, Boom, M, Marsman, W A, Stockmann, H B, Mol, B, de Groof, A J, Stokkers, P C, D'Haens, G R, Bemelman, W A, LIR!C study group & LIR!C study group 2017, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : a randomised controlled, open-label, multicentre trial ', The Lancet Gastroenterology and Hepatology, vol. 2, no. 11, pp. 785-792 . https://doi.org/10.1016/S2468-1253(17)30248-0
Lancet Gastroenterology & Hepatology, 2(11), 785-792. Elsevier Ltd.
The Lancet Gastroenterology and Hepatology, 2(11), 785-792. Elsevier Ltd
lancet. Gastroenterology & hepatology, 2(11), 785-792. Elsevier Limited

Background Treatment of patients with ileocaecal Crohn's disease who have not responded to conventional therapy is commonly scaled up to biological agents, but surgery can also offer excellent short-term and long-term results. We compared laparoscopi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb34b19ce17cea4fe23427f76644e5c7
https://doi.org/10.1016/s2468-1253(17)30248-0

Balloon dilatation with or without intralesional and oral corticosteroids for anastomotic Crohn's disease strictures

Autor: Peter D. Siersema, Casper G. Noomen, Mike van der Have, Herma H. Fidder, Martin H. Houben, Bas Oldenburg, Daan Hommes, Martin N. J. M. Wasser, Daisy Walter

Publikováno v: Journal of Gastrointestinal and Liver Diseases, 24, 4, pp. 537-9
Journal of Gastrointestinal and Liver Diseases, 24(4), 537-539
Journal of Gastrointestinal and Liver Diseases, 24, 537-9
Web of Science
Journal of Gastroenterology and Liver Diseases, 24(4), 537

Contains fulltext : 151967.pdf (Publisher’s version ) (Open Access)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7276743b800832933df42d6e4a345c
https://doi.org/10.15403/jgld.2014.1121.244.hav